Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 35,577 | 7,566 | 5,124 | 9,032 | 12,000 |
| Cost of Goods | 3,441 | 2,740 | 746 | 725 | N/A |
| Gross Profit | 32,136 | 4,826 | 4,378 | 8,307 | 12,000 |
| Operating Expenses | 44,762 | 71,485 | 70,883 | 30,328 | 42,908 |
| Operating Income | -12,185 | -65,919 | -65,759 | -21,296 | -30,908 |
| Interest Expense | 7,742 | 9,412 | 3,962 | 2,172 | 4,295 |
| Other Income | 2,041 | -1,248 | 2,726 | -1,019 | 123 |
| Pre-tax Income | -17,886 | -76,579 | -66,995 | -24,487 | -35,080 |
| Net Income Continuous | -17,886 | -76,579 | -66,995 | -24,487 | -35,080 |
| Net Income | $-17,886 | $-76,579 | $-66,995 | $-24,487 | $-35,080 |
| EPS Basic Total Ops | -1.68 | -14.78 | -14.80 | -7.20 | -13.00 |
| EPS Basic Continuous Ops | -1.68 | -14.78 | -14.78 | -7.17 | -12.97 |
| EPS Diluted Total Ops | -1.68 | -14.78 | -14.80 | -7.20 | -13.00 |
| EPS Diluted Continuous Ops | -1.68 | -14.78 | -14.78 | -7.17 | -12.97 |
| EPS Diluted Before Non-Recurring Items | -1.55 | -14.80 | -11.40 | -6.60 | -12.50 |
| EBITDA(a) | $-11,404 | $-64,650 | $-64,923 | $-20,470 | $-30,370 |